FDA — authorised 25 July 1991
- Application: NDA019834
- Marketing authorisation holder: ASTRAZENECA
- Local brand name: PLENDIL
- Indication: TABLET, EXTENDED RELEASE — ORAL
- Status: approved
FDA authorised PLENDIL® on 25 July 1991
Yes. FDA authorised it on 25 July 1991.
ASTRAZENECA holds the US marketing authorisation.